Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-16 4:35 pm Purchase |
2024-10-11 | 13D | Interpace Biosciences, Inc. IDXG |
1315 Capital II L.P. | 9,405,940 68.000% |
6,239,274 (+197.03%) |
Filing History |
| 2021-11-12 5:21 pm Unchanged |
2021-11-01 | 13D | Interpace Biosciences, Inc. IDXG |
1315 Capital II L.P. | 3,166,666 26.400% |
0 (Unchanged) |
Filing History |
| 2021-06-24 07:30 am Purchase |
2021-06-14 | 13D | GREENBROOK TMS INC GBNHF |
1315 Capital II L.P. | 2,074,521 12.900% |
2,074,521 (New Position) |
Filing History |
| 2021-05-19 5:39 pm Unchanged |
2021-05-10 | 13D | Interpace Biosciences, Inc. IDXG |
1315 Capital II L.P. | 3,166,666 26.500% |
0 (Unchanged) |
Filing History |
| 2021-01-21 4:49 pm Unchanged |
2021-01-07 | 13D | Interpace Biosciences, Inc. IDXG |
1315 Capital II L.P. | 3,166,666 26.600% |
0 (Unchanged) |
Filing History |
| 2020-04-30 08:15 am Unchanged |
2020-04-02 | 13D | Interpace Biosciences, Inc. IDXG |
1315 Capital II L.P. | 3,166,666 26.700% |
0 (Unchanged) |
Filing History |